Contact
    Start Publications Conducting Polymer-Coated Carbon Cloth Captures and Releases ...
    ←  Publication Finder
    Attension

    Conducting Polymer-Coated Carbon Cloth Captures and Releases Extracellular Vesicles by a Rapid and Controlled Redox Process

    Year: 2022

    Journal: ACS Appl. Mater. Interfaces, Volume 14, JUL 27, page 32880–32889

    Authors: Ashraf, Jesna; Akbarinejad, Alireza; Hisey, Colin L.; Bryant, Devon T.; Wang, Julie; Zhu, Bicheng; Evans, Clive W.; Williams, David E.; Chamley, Lawrence W.; Barker, David; Pilkington, Lisa I.; Travas-Sejdic, Jadranka

    Organizations: Ministry of Business, Innovation and Employment [CONT- 50975-ENDSI-UOA]

    Keywords: carbon cloth; conducting polymer; electrochemically switchable; antibody; extracellular vesicles; electrochemical release; trastuzumab; HER2

    Electrochemical techniques offer great opportunities for the capture of chemical and biological entities from complex mixtures and their subsequent release into clean buffers for analysis. Such methods are clean, robust, rapid, and compatible with a wide range of biological fluids. Here, we designed an electrochemically addressable system, based on a conducting terpolymer [P(EDOT-co-EDOTSAc-co-EDOTEG)] coated onto a carbon cloth substrate, to selectively capture and release biological entities using a simple electrochemical redox process. The conducting terpolymer composition was optimized and the terpolymer-coated carbon cloth was extensively characterized using electrochemical analysis, Raman and Fourier transform-infrared spectroscopy, water contact angle analysis, and scanning electron microscopy. The conductive terpolymer possesses a derivative of EDOT with an acetylthiomethyl moiety (EDOTSAc), which is converted into a free thiol that then undergoes reversible oxidation/reduction cycles at +1.0 V and -0.8 V (vs Ag/AgCl), respectively. That redox process enables electrochemical capture and on-demand release. We first demonstrated the successful electrochemical capture/release of a fluorescently labeled IgG antibody. The same capture/release procedure was then applied to release extracellular vesicles (EVs), originating from both MCF7 and SKBR3 breast cancer cell line bioreactors. EVs were captured using the substrate-conjugated HER2 antibody which was purified from commercially available trastuzumab. Capture and release of breast cancer EVs using a trastuzumab-derived HER2 antibody has not been reported before (to the best of our knowledge). A rapid (2 min) release at a low potential (-0.8 V) achieved a high release efficiency (>70%) of the captured, HER2(+ve), SKBR3 EVs. The developed system and the electrochemical method are efficient and straightforward and have vast potential for the isolation and concentration of various biological targets from large volumes of biological and other (e.g., environmental) samples.
    View publication